Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Voyager Therapeutics
VYGR
$198M
| $2.85M | ﹤0.01% |
204,587
+5,299
| +3% | +$77K |
|
2302
Byline Bancorp
BY
$1.78B
| $2.85M | ﹤0.01% |
145,652
+3,005
| +2% | +$54.9K |
|
2303
Gates Industrial Corporation Ltd.
GTES
$7B
| $2.85M | ﹤0.01% |
207,122
+3,732
| +2% | +$42.5K |
|
2304
Mitek Systems
MITK
$853M
| $2.85M | ﹤0.01% |
372,253
+285,342
| +328% | +$2.41M |
|
2305
PetMed Express
PETS
$43.4M
| $2.84M | ﹤0.01% |
120,882
+2,220
| +2% | +$49.7K |
|
2306
Funko
FNKO
$335M
| $2.84M | ﹤0.01% |
165,649
+10,202
| +7% | +$167K |
|
|
GPOR
2307
DELISTED
Gulfport Energy Corp.
GPOR
| $2.84M | ﹤0.01% |
934,372
+19,301
| +2% | +$54.8K |
|
2308
Nexa Resources
NEXA
$1.9B
| $2.83M | ﹤0.01% |
347,354
+53,383
| +18% | +$487K |
|
2309
Winmark
WINA
$1.26B
| $2.81M | ﹤0.01% |
14,191
+646
| +5% | +$116K |
|
|
BRY
2310
DELISTED
Berry Corp
BRY
| $2.81M | ﹤0.01% |
298,028
+5,719
| +2% | +$53.5K |
|
|
AXDX
2311
DELISTED
Accelerate Diagnostics
AXDX
| $2.79M | ﹤0.01% |
16,523
+324
| +2% | +$53.5K |
|
2312
Radiant Logistics
RLGT
$406M
| $2.78M | ﹤0.01% |
498,354
+4,866
| +1% | +$26.3K |
|
2313
Equity Bancshares
EQBK
$1.07B
| $2.75M | ﹤0.01% |
89,187
+986
| +1% | +$28.2K |
|
|
CLCT
2314
DELISTED
Collectors Universe
CLCT
| $2.75M | ﹤0.01% |
119,407
+20,683
| +21% | +$554K |
|
2315
Adaptive Biotechnologies
ADPT
$3.89B
| $2.75M | ﹤0.01% |
91,896
+1,795
| +2% | +$51.5K |
|
2316
Phreesia
PHR
$780M
| $2.74M | ﹤0.01% |
102,821
+32,430
| +46% | +$896K |
|
|
COWN
2317
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $2.73M | ﹤0.01% |
173,287
-667
| -0.4% | -$10K |
|
2318
Hawkins
HWKN
$2.67B
| $2.73M | ﹤0.01% |
119,040
-11,128
| -9% | -$236K |
|
|
PGNX
2319
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.73M | ﹤0.01% |
535,181
+18,009
| +3% | +$95.3K |
|
|
DHIL
2320
DELISTED
Diamond Hill
DHIL
| $2.72M | ﹤0.01% |
19,390
+181
| +0.9% | +$25.3K |
|
|
OMN
2321
DELISTED
OMNOVA Solutions Inc.
OMN
| $2.72M | ﹤0.01% |
269,058
-2,041
| -0.8% | -$20.6K |
|
|
CRC
2322
DELISTED
California Resources Corporation
CRC
| $2.71M | ﹤0.01% |
299,946
+6,460
| +2% | +$52.3K |
|
|
HAYN
2323
DELISTED
Haynes International, Inc.
HAYN
| $2.71M | ﹤0.01% |
75,653
+1,575
| +2% | +$56.8K |
|
|
CBL
2324
DELISTED
CBL& Associates Properties, Inc.
CBL
| $2.69M | ﹤0.01% |
2,566,592
+50,611
| +2% | +$66.2K |
|
2325
Forrester Research
FORR
$224M
| $2.68M | ﹤0.01% |
64,205
+1,431
| +2% | +$53.4K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.